Status:
COMPLETED
Safety and Efficacy of Hoodia Gordonii for Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Non-Alcoholic Fatty Liver Disease
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
This clinical study is designed to evaluate the safety of oral administration of the medical food Hoodia to patients with non alcoholic fatty liver disease. Oral administration of Hoodia is common in...
Eligibility Criteria
Inclusion
- Subjects who have completed the informed consent process culminating with written informed consent by the subject
- Men and women age 18 to 65 years inclusive.
- Patients with biopsy proven NASH with a score of 4 or above.
- Altered glucose metabolism, including diabetes (non treated, or treated with up to 2 drugs (not including insulin) without any change in medication 2 months prior to enrolment), impaired fasting glucose or impaired glucose tolerance.
- HBA1C between 5.5 and 14%.
Exclusion
- \-
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2010
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00816465
Start Date
May 1 2009
End Date
August 1 2010
Last Update
September 17 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical Center
Jerusalem, Israel, 91120